BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 29093267)

  • 21. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.
    Jha P; Claudel T; Baghdasaryan A; Mueller M; Halilbasic E; Das SK; Lass A; Zimmermann R; Zechner R; Hoefler G; Trauner M
    Hepatology; 2014 Mar; 59(3):858-69. PubMed ID: 24002947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
    Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
    Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
    Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H
    J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.
    González-Rodríguez Á; Valdecantos MP; Rada P; Addante A; Barahona I; Rey E; Pardo V; Ruiz L; Laiglesia LM; Moreno-Aliaga MJ; García-Monzón C; Sánchez A; Valverde ÁM
    Mol Metab; 2018 Jan; 7():132-146. PubMed ID: 29126873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH).
    Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I
    Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    Kammoun HL; Allen TL; Henstridge DC; Kraakman MJ; Peijs L; Rose-John S; Febbraio MA
    PLoS One; 2017; 12(6):e0179099. PubMed ID: 28632778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
    World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
    Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
    J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH.
    Zanieri F; Levi A; Montefusco D; Longato L; De Chiara F; Frenguelli L; Omenetti S; Andreola F; Luong TV; Massey V; Caballeria J; Fondevila C; Shanmugavelandy SS; Fox T; Mazza G; Argemi J; Bataller R; Cowart LA; Kester M; Pinzani M; Rombouts K
    Cells; 2020 May; 9(5):. PubMed ID: 32429478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conophylline inhibits non-alcoholic steatohepatitis in mice.
    Nakade Y; Sakamoto K; Yamauchi T; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Sumida Y; Ito K; Nakao H; Fukuzawa Y; Umezawa K; Yoneda M
    PLoS One; 2017; 12(6):e0178436. PubMed ID: 28594915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
    Loyer X; Paradis V; Hénique C; Vion AC; Colnot N; Guerin CL; Devue C; On S; Scetbun J; Romain M; Paul JL; Rothenberg ME; Marcellin P; Durand F; Bedossa P; Prip-Buus C; Baugé E; Staels B; Boulanger CM; Tedgui A; Rautou PE
    Gut; 2016 Nov; 65(11):1882-1894. PubMed ID: 26338827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
    Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD.
    Deng M; Qu F; Chen L; Liu C; Zhang M; Ren F; Guo H; Zhang H; Ge S; Wu C; Zhao L
    J Endocrinol; 2020 Jun; 245(3):425-437. PubMed ID: 32302970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.
    Nicholls HT; Hornick JL; Cohen DE
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G50-G61. PubMed ID: 28385694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice.
    Ahsan MK; Okuyama H; Hoshino Y; Oka S; Masutani H; Yodoi J; Nakamura H
    Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Hu X; Lu Y; Fujimori N; Golla S; Fang ZZ; Aoyama T; Krausz KW; Gonzalez FJ
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3170-3182. PubMed ID: 28844958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities.
    Rein-Fischboeck L; Haberl EM; Pohl R; Feder S; Liebisch G; Krautbauer S; Buechler C
    Lipids Health Dis; 2019 Sep; 18(1):172. PubMed ID: 31521175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
    Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
    Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.